Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Selective whole genome amplification and sequencing of ape-infective relatives of Plasmodium malariae

PROVIDER: PRJNA767638 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16133634_1.fastq.gz	Fastqsanger.gz
	SRR16133634_2.fastq.gz	Fastqsanger.gz
	SRR16133635_1.fastq.gz	Fastqsanger.gz
	SRR16133635_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Plasmodium malariae selective whole genome amplification development

Project description:Plasmodium malariae selective whole genome amplification development

| PRJEB37746 | ENA

Project description:Ape Plasmodium vivax selective whole genome amplification

| PRJNA474492 | ENA

Plasmodium falciparum

Project description:Plasmodium falciparum selective whole genome amplification (sWGA)

| PRJNA1110244 | ENA

SWGA

Project description:Selective whole genome amplification

| PRJEB6142 | ENA

SWGA of Plasmodium malariae

Project description:Selective Whole Genome Amplification of Plasmodium malariae DNA from clinical samples reveals high genetic diversity and population structure of this neglected malaria parasite

| PRJEB33837 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Plasmodium malariae

Project description:Nuclear genome sequences of Plasmodium malariae.

| PRJEB12680 | ENA

Project description:Hybrid capture sequencing of Plasmodium malariae

| PRJNA1157442 | ENA

Genomes of P. ovale and P. malariae

Project description:The genome sequences of Plasmodium ovale and Plasmodium malariae

| PRJEB14392 | ENA

Project description:Selective whole-genome amplification of Leishmania braziliensis from patient biopsies

| PRJNA875085 | ENA